Project Overview
Ovarian cancer is the third most common gynecologic cancer in India, with nearly 60,000 new cases reported annually and high mortality due to late detection. Five-year survival rates drop drastically from 90% at early stages to below 30% in advanced stages. With no widely available POC solutions, the market represents an innovation gap estimated to grow at 10 to 12% CAGR, driven by rising awareness in women health and expanding oncology services.
